Santiago, Chile

Gonzalo Andrés Ureta Díaz

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gonzalo Andrés Ureta Díaz

Introduction

Gonzalo Andrés Ureta Díaz is a prominent inventor based in Santiago, Chile. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. With a total of 4 patents to his name, Ureta Díaz is recognized for his innovative approaches to addressing complex medical challenges.

Latest Patents

Among his latest patents, Ureta Díaz has developed inhibitors of fibroblast activation protein. These compounds and compositions are designed to modulate fibroblast activation protein (FAP) and may serve as therapeutic agents for treating hyperproliferative diseases. Additionally, he has worked on modulators of the integrated stress response pathway, which are therapeutic agents that can be useful in regulating the Integrated Stress Response (ISR) pathway.

Career Highlights

Ureta Díaz is currently associated with Praxis Biotech LLC, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that can improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Ureta Díaz has collaborated with notable colleagues, including Brahmam Pujala and Dayanand Panpatil. These partnerships have contributed to the success of his projects and the advancement of biotechnology.

Conclusion

Gonzalo Andrés Ureta Díaz exemplifies the spirit of innovation in the biotechnology sector. His patents and ongoing research reflect a commitment to improving healthcare through scientific advancements. His contributions are paving the way for new therapeutic options that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…